Clinical Trial Update: Endometrial Cancer Recurrence in Patients Taking Metformin

View source ↗

Summary

The clinical trial investigating metformin in patients with recurrent endometrial cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: WellSpan Health | Conditions: Recurrent Endometrial Carcinoma | Status: WITHDRAWN